Better life with

your own stem cells

Your stem cells, our technology

for a disease-free future

Bringing hope through

the power of stem cells

About us

Establishment of a robust
& safe stem cell therapy

We aim to achieve safe, economical, and practical autologous cell transplantation
therapy using induced pluripotent stem cell (iPSC) technology.

Robust and safe
iPSC bank

Robust and safe
iPSC bank

Establishment of robust and safe
iPSC bank;
CTX is establishing highly qualified
clinical-grade iPSC bank ready to be
utilized for cell therapy applications.

iPSC manufacturing
pipelines

iPSC
manufacturing
pipelines

Developing comprehensive iPSC
manufacturing pipelines, ensuring
the safety and functionality of cell
products for cell transplantation
therapy.

Protocols for cell
transplantation

Protocols for
cell transplantation

Upgrading protocols for cell
transplantation with chemical and
molecular reagents that enhance the
successful functional integration into
the destined tissues.

Personalized
platform

Personalized
platform

Developing a personalized platform
to screen optimal treatments using
patient-derived iPSC models,
including 3D organoid systems.

What we do

Regenerative Medicine

Regenerative medicine is the field of medicine that restores normal function by repairing or
replacing damaged cells, tissues, or organs. The expansion of stem cell-based products is
a key driver of the rapid growth of the regenerative medicine market.

Pipeline

iPSCs-based Cell Therapy for PD

We aim to achieve safe, economical, and practical autologous cell transplantation therapy using induced pluripotent stem cell (iPSC) technology.

CTX-PD01

CTX-PD01 is a CTX’s autologous cell therapy for Parkinson’s disease.

CTX-PD02/03

CTX-PD02/03 improve functional recovery of transplanted neurons.

CTX-ED01/02

CTX-ED01/02 are CTX’s iPSC-based tissue/ cell therapies for
ocular diseases.

CTX-HyiPSC

CTX-HyiPSC is one of the most encouraging medical procedures in the field of regenerative medicine.

iPSC Banking

CTX-SCB, our dedicated iPSC bank, focuses on creating and
preserving clinical grade iPSCs for personalized stem cell-based
healthcare.

CTX-FBO/MBO

CTX's brain organoid, known as a 'mini-brain,' is a 3D tissue model
crafted from human iPSCs, possessing a high degree of functional
and structural similarity to the human brain.

Press Release

Here's an update

Check out various news about CTX.

2023-09-01

2023 WBF 여성생명과학기술포럼 참석

김남식 연구소장, 파킨슨병 치료를 위한 자가유래 iPSC 기반 세포치료제 발표 제 7회 WBF 연수강좌 참석자 단체사진

2022-07-27

제2회 파킨슨병 살롱 성료…파킨슨병 치료전략 및 세포치료제 연구성과 공유

| 30여명 이상의 신경외과/신경과 임상의, 국내 세포치료제 개발 기업 관계자 등 참석| 파킨슨병에 대한 세포치료제의 임상 성공 가능성 높이는 전략 모색제2회 파킨슨병 살롱에서는 30명 이상의 파킨슨병 전문가들이 모여 파킨슨병의 신약 개발 성과 및 임상적 치료 방법에 대해 공유했다(사진=에임드바이오) [바이오타임즈] 뇌 질환 혁신 신약 개

2021-02-19

KAIST-원진 세포치료센터 기부 및 투자 약정 업무협약

2021년 2월 19일(금), 신성철 총장은 우리 대학 본관 제1회의실에서 ‘KAIST-원진 세포치료센터 기부 및 투자 약정 업무협약식’을 가졌다. 신성철 총장은 인사말을 통해 “세포치료센터 출범과 줄기세포치료 연구를 위한 기부를 해 주신 박원진 회장님과 세포치료센터 설립을 제안하신 김광수 교수님께 감